Twist Bioscience Corporation — Income Charts
8 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue↑+16.9% +$15M
$104M
Cost of Revenue↑+8.4% +$4M
$50M
R&D↓-19.6% -$4M
$17M
SG&A↑+24.1% +$14M
$70M
D&A↓-2.9% -$186K
$6M
Operating Income↑+5.0% +$2M
$-33M
EBITDA↑+5.5% +$2M
$-27M
Interest Expense
$143K
Interest Income
$100K
Other Income/Expense↓-19.7% -$625K
$3M
Pretax Income↑+3.9% +$1M
$-30M
Tax Provision↑+160.8% +$156K
$253K
Net Income↑+3.4% +$1M
$-31M
Operating Margin↑+7.3pts
-31.7%
Net Margin↑+6.2pts
-29.4%
Effective Tax Rate↓-0.5pts
-0.8%
ETR (Continuing Operations)↓-1.0pts
-1.0%
ETR Federal Statutory↑+0.0pts
21.0%
Operating Lease Cost↓-4.9% -$182K
$4M
Revenue YoY Variation↓-7.2pts
16.9%
Income YoY Variation↓-21.2pts
5.0%
Revenue QoQ Variation↑+0.0pts
4.7%
Income QoQ Variation↑+109.4pts
27.5%